Australia urged to manufacture mRNA Covid vaccines onshore to guard against supply disruption

Without the technology to produce mRNA vaccines such as the Pfizer jab, Australia and region remain vulnerable to supply shocks', scientists warn

Leading Australian scientists have called on the federal government to urgently develop additional onshore Covid vaccine manufacturing capability to protect against supply disruption as the country completes its second day of vaccinations.

In a pre-budget submission published on Tuesday, the Australian Academy of Science said without the ability to produce mRNA vaccines, Australia and the region remain vulnerable to supply limitations.